MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) today announced the closing of its previously announced $100 million private investment in public equity (PIPE) financing. This ...
Apimeds Pharmaceuticals US, Inc. (APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio ...